ProMIS Neurosciences Statistics
Want to see PMN full AI Analyst Report?
ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics
Total Valuation
ProMIS Neurosciences has a market cap or net worth of $35.69M. The enterprise value is $66.85M.
- Market Cap
- $35.69M
- Enterprise Value
- $66.85M
Share Statistics
ProMIS Neurosciences has 8,967,693 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,967,693
- Owned by Insiders
- 13.85%
- Owned by Institutions
- 45.61%
Financial Efficiency
ProMIS Neurosciences’s return on equity (ROE) is 31.56 and return on invested capital (ROIC) is 3267.20%.
- Return on Equity (ROE)
- 31.56
- Return on Assets (ROA)
- -4.33
- Return on Invested Capital (ROIC)
- 3267.20%
- Return on Capital Employed (ROCE)
- 32.67
- Revenue Per Employee
- 0
- Profits Per Employee
- -3.61M
- Employee Count
- 11
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of ProMIS Neurosciences is -0.22. ProMIS Neurosciences’s PEG ratio is 0.00.
- PE Ratio
- -0.22
- PS Ratio
- 0.00
- PB Ratio
- 0.70
- Price to FCF
- -0.80
- Price to Operating Cash Flow
- -0.82
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, ProMIS Neurosciences had revenue of 0 and earned -39.72M in profits. Earnings per share was -22.61.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -40.17M
- Pretax Income
- -39.72M
- Net Income
- -39.72M
- EBITDA
- -39.72M
- Earnings Per Share (EPS)
- -22.61
Cash Flow
In the last 12 months, operating cash flow was -42.00M and capital expenditures 0, giving a free cash flow of -42.00M billion.
- Operating Cash Flow
- -42.00M
- Free Cash Flow
- -42.00M
- Free Cash Flow per Share
- -4.59
Dividends & Yields
ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -126.59%
- Earnings Yield
- -124.84%
Stock Price Statistics
- Beta
- 0.24
- 52-Week Price Change
- -61.92%
- 50-Day Moving Average
- 10.12
- 200-Day Moving Average
- 12.83
- Relative Strength Index (RSI)
- 32.07
- Average Volume (3m)
- 151.22K
Important Dates
ProMIS Neurosciences upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
ProMIS Neurosciences as a current ratio of 0.88, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.88
- Quick Ratio
- 0.88
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.15
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, ProMIS Neurosciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
ProMIS Neurosciences EV to EBITDA ratio is 0.47, with an EV/FCF ratio of 0.48.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.47
- EV to Free Cash Flow
- 0.48
- EV to Operating Cash Flow
- 0.48
Balance Sheet
ProMIS Neurosciences has $53.46M in cash and marketable securities with $0.00 in debt, giving a net cash position of $53.46M billion.
- Cash & Marketable Securities
- $53.46M
- Total Debt
- $0.00
- Net Cash
- $53.46M
- Net Cash Per Share
- $5.96
- Tangible Book Value Per Share
- $5.40
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for ProMIS Neurosciences is $40.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $40.20
- Price Target Upside
- 969.15% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -169.38%
Scores
- Smart Score
- 6
- AI Score
- 42
